Prognostic factors of disease progression in patients with mild-to-moderate COVID-19 on early remdesivir treatment in Taiwan

Background: An early 3-day course of remdesivir treatment was recommended for high risk patients with mild-to-moderate COVID-19. We investigated the prognostic factors of disease progression and mortality in patients with mild-to-moderate COVID-19 on early remdesivir treatment in Taiwan. Methods: Ad...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yu-Chien Ho, Min-Chi Chang, Wen-Ying Lin, Chia-Ying Wu, Szu-Yu Liu, Chien Chuang, Chih-Han Juan, Chia-Jen Liu, Yi-Tsung Lin
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2025-05-01
Col·lecció:	Journal of Infection and Public Health
Matèries:	Early remdesivir COVID-19 Clinical outcomes Nosocomial COVID-19
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S1876034125000541
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!